Cryptococcus neoformans Ex Vivo Capsule Size Is Associated With Intracranial Pressure and Host Immune Response in HIV-associated Cryptococcal Meningitis
Author(s) -
Emma J. Robertson,
Grace Najjuka,
Melissa A. Rolfes,
Andrew Akampurira,
Neena Jain,
Janani Anantharanjit,
Maximilian von Hohenberg,
Manlio Tassieri,
Allan Carlsson,
David B. Meya,
Thomas S. Harrison,
Bettina C. Fries,
David R. Boulware,
Tihana Bicanic
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit435
Subject(s) - cryptococcus neoformans , cryptococcosis , cryptococcal meningitis , ex vivo , immune system , meningitis , cryptococcus , immunology , microbiology and biotechnology , biology , aids related opportunistic infections , virology , human immunodeficiency virus (hiv) , in vivo , medicine , sida , viral disease , psychiatry
The Cryptococcus neoformans polysaccharide capsule is a well-characterized virulence factor with immunomodulatory properties. The organism and/or shed capsule is postulated to raise intracranial pressure (ICP) in cryptococcal meningitis (CM) by mechanical obstruction of cerebrospinal fluid (CSF) outflow. Little is known regarding capsule phenotype in human cryptococcosis. We investigated the relationship of ex vivo CSF capsular phenotype with ICP and CSF immune response, as well as in vitro phenotype.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom